iNtRON Biotechnology Inc operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares iNtRON Biotechnology Inc with three other
companies in this sector in KOREA (SOUTH) :
FutureChem Co Ltd
sales of 8.17 billion Korean Won [US$7.24 million]
(4.37 billion Korean Won [US$3.87 million]
of which 67%
was Medical Segment), and
Cube&Company Co Ltd
(7.38 billion Korean Won [US$6.54 million]
of which 98%
iNtRON Biotechnology Inc reported sales of 8.35 billion Korean Won (US$7.40 million)
December of 2019.
decrease of 59.4%
versus 2018, when the company's sales were 20.58 billion Korean Won .